ArticleNature communications2022
Selective optogenetic control of G
Erratum issuedOpen access · goldAbstract read
In one paragraph
Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 26 papers.
0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
4.2field-weighted citation impact, top 4% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed, 51 citations in OpenAlex.
- From pineal photoreception to optogenetics: functional colour opponency based on a pineal bistable opsin.Eye and vision (London, England) · 2026Review
- Efficient and sustained optogenetic control of sensory and cardiac systems.Nature biomedical engineering · 2026Article
- Light and myopia: a focus on the expanding role of non-visual opsins.Eye and vision (London, England) · 2026Review
- Non-visual opsins and their role in circadian photoentrainment.Eye and vision (London, England) · 2026Review
- Optogenetic engineering of synthetic and natural receptors: design principles, functional mechanisms and biomedical applications.Regenerative biomaterials · 2026Review
- The physiological functions of OPN5m.Eye and vision (London, England) · 2025Review
- Discovery and design of photocyclic animal opsins: potential application to gene therapy from non-visual opsin research.Eye and vision (London, England) · 2025Review
- Two Decades of Optogenetic Tools: A Retrospective and a Look Ahead.Advanced genetics (Hoboken, N.J.) · 2025Review
- Development of visible light-sensitive human neuropsin (OPN5) via single amino acid substitution.FEBS letters · 2025Article
- Direct Stimulation of Gastric Smooth Muscle Cells via GNeurogastroenterology and motility · 2025Article
- Optogenetic engineering for ion channel modulation.Current opinion in chemical biology · 2025Review
- Neuropsin, TRPV4 and intracellular calcium mediate intrinsic photosensitivity in corneal epithelial cells.The ocular surface · 2025Article
- A bistable inhibitory optoGPCR for multiplexed optogenetic control of neural circuits.Nature methods · 2024Article
- Cardiac optogenetics: shining light on signaling pathways.Pflugers Archiv : European journal of physiology · 2023Review
- Modulating signalling lifetime to optimise a prototypical animal opsin for optogenetic applications.Pflugers Archiv : European journal of physiology · 2023Article
- Foxo3 Knockdown Mediates Decline ofCells · 2023Article
- Optogenetic manipulation of Gq- and Gi/o-coupled receptor signaling in neurons and heart muscle cells.eLife · 2023Article
- A bistable inhibitory OptoGPCR for multiplexed optogenetic control of neural circuits.bioRxiv : the preprint server for biology · 2023Article
- Molecular Mechanisms of the Melatonin Receptor Pathway Linking Circadian Rhythm to Type 2 Diabetes Mellitus.Nutrients · 2023Review
- Multiple opsins in a reef-building coral, Acropora millepora.Scientific reports · 2023Article
Corrections and comments
- Erratum issued
Authors and funding
18 authors at 5 institutions in 1 country.
Ahmed Wagdi *Institute for Cardiovascular Physiology, University Medical Center Göttingen, Göttingen, Germany.ORCID http://orcid.org/0000-0002-7952-9307
Daniela Malan *Institute of Physiology I, Medical Faculty, University of Bonn, Bonn, Germany.
Udhayabhaskar Sathyanarayanan *Institute for Cardiovascular Physiology, University Medical Center Göttingen, Göttingen, Germany.
Janosch S BeauchampInstitute for Cardiovascular Physiology, University Medical Center Göttingen, Göttingen, Germany.
Markus VogtInstitute for Cardiovascular Physiology, University Medical Center Göttingen, Göttingen, Germany.
David ZipfInstitute for Cardiovascular Physiology, University Medical Center Göttingen, Göttingen, Germany.
Thomas BeiertDepartment of Internal Medicine II, University Hospital Bonn, University of Bonn, Bonn, Germany.
Berivan MansurogluInstitute of Physiology I, Medical Faculty, University of Bonn, Bonn, Germany.
Vanessa DusendInstitute of Physiology I, Medical Faculty, University of Bonn, Bonn, Germany.ORCID http://orcid.org/0000-0001-7561-0178
Mark MeininghausBayer AG, Research & Development, Pharmaceuticals, 42096, Wuppertal, Germany.ORCID http://orcid.org/0000-0003-0388-2128
Linn SchneiderBayer AG, Research & Development, Pharmaceuticals, 42096, Wuppertal, Germany.
Bernd KalthofBayer AG, Research & Development, Pharmaceuticals, 42096, Wuppertal, Germany.
J Simon WiegertCenter for Molecular Neurobiology Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID http://orcid.org/0000-0003-0893-9349
Gabriele M KönigMolecular, Cellular and Pharmacobiology Section, Institute of Pharmaceutical Biology, University of Bonn, Bonn, Germany.
Evi KostenisMolecular, Cellular and Pharmacobiology Section, Institute of Pharmaceutical Biology, University of Bonn, Bonn, Germany.ORCID http://orcid.org/0000-0001-8284-5514
Robert PatejdlOscar-Langendorff Institute of Physiology, Rostock University Medical Center, Rostock, Germany.
Philipp SasseInstitute of Physiology I, Medical Faculty, University of Bonn, Bonn, Germany. philipp.sasse@uni-bonn.de.ORCID http://orcid.org/0000-0002-8502-9472
Tobias BruegmannInstitute for Cardiovascular Physiology, University Medical Center Göttingen, Göttingen, Germany. tobias.bruegmann@med.uni-goettingen.de.ORCID http://orcid.org/0000-0002-6930-9634
University of Bonn · DEUniversitätsmedizin Göttingen · DEBayer (Germany) · DEUniversität Hamburg · DEUniversity of Rostock · DE
Funding
No grant is acknowledged in the PubMed record.
Abstract
G
Indexed as
OptogeneticsSignal TransductionAnimalsHumansLightMammalsTRPC6 Cation ChannelTRPC6 Cation Channel
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.